Concepedia

A Comparative Analysis of the Impact of a Positive List System on New Chemical Entity Drugs and Incrementally Modified Drugs in South Korea

Dongmun Ha, Yong-Jun Choi, Dae Up Kim, Kyu Hyuck Chung, Eui‐Kyung Lee

Clinical Therapeutics · 2011 · 13 citations · 5 references

DOI

Concepts

References

5

Guidelines for Economic Analysis of Pharmaceutical Products

Allan S. Detsky · PharmacoEconomics · 1993 · 143 citations

, , +14

Economic Evaluation And Pharmaceutical Reimbursement Reform In South Korea’s National Health Insurance

Bong‐Min Yang, Eun-young Bae, Jinhyun Kim · Health Affairs · 2008 · 71 citations

, , +17

Ontario??s Formulary Committee

Anne M PausJenssen, Peter Singer, Allan S. Detsky · PharmacoEconomics · 2003 · 58 citations

Technology assessment and cost-effectiveness analysis: misguided guidelines?

C. David Naylor, J. I. Williams, Antoni Basinski et al. · PubMed · 1993 · 44 citations · Full text

, , +11

Pharmacoeconomic Guidelines and Their Implementation in the Positive List System in South Korea

Eun Young Bae, Eui Kyung Lee · Value in Health · 2009 · 42 citations

, , +12